Refine by
Applications
- Solutions for Endometriosis
- Solutions for Severe but Non-Specific Symptoms
- RNA Technology for Research Fellowship
- RNA Technology for Medical Areas of Focus Research
- RNA Technology for Product Pipeline Research
- RNA Technology for Clinical trials
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Medical diagnostics solutions for inflammatory bowel disease sector
- Medical diagnostics solutions for colorectal cancer sector
- Klarity - Built Therapeutic Platform Technologies for Gastrointestinal Disease
- Klarity - Built Therapeutic Platform Technologies for Neurological Disorders
- Klarity - Built Therapeutic Platform Technologies for Metabolism
Disease Target Equipment & Supplies
62 equipment items found
by:Intellia Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
Genome editing is efficient, precise and scalable. CRISPR/Cas9 genome editing can make permanent, precisely targeted changes in patients’ chromosomes and repair the underlying genetic mutation, whereas more traditional gene therapy typically involves introducing a non-permanent copy of a gene into patients’ cells. These attributes of CRISPR/Cas9 provide a significant ...
by:Genome Biologics based inFrankfurt am Main, GERMANY
GENIMAPS® and GENISYST® technology integration facilitates Ai-driven target identification, and direct therapeutic interrogation of RNAi disease targets in vitro (2D and 3D), and in small and large animal models. This coupled workflow enables efficient and accelerated RNAi target discovery and efficacy ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
AD1801 is an innovative project to develop disease modifying treatment of Alzheimer’s disease, targeting Apolipoprotein E (ApoE), a different molecule than those targeted in the projects BAN2401 and BAN2401 ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
It is an artificial intelligence technology that can predict biomarkers, prognostic biomarkers and even the mode of action (MOA) of disease ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies. A broader window of opportunity. Deliver potent cell-killing compounds specifically to diseased target cells with optimal safety and efficacy. ZymeLink™, a next-generation antibody drug conjugate (ADC) platform, is a suite of proprietary ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
We design and manufacture therapeutics against disease targets that have been inaccessible to the biopharmaceutical industry because of the astonishingly high cost of traditional methods. Now, for the first time, Lumen can make antibodies and other biologics at a cost that allows for daily, high-dose, oral and topical delivery. Our current programs ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Peptides are an increasingly important class of drug. As natural ligands to many targets, they can combine agonistic or antagonistic activity with low toxicity risk and can be applied to disease targets, where small molecules or antibody-based drugs cannot be used. However, the number of therapeutic peptide drugs is held back by properties that ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
The versatile Xoft Axxent® Electronic Brachytherapy (eBx) System utilizes breakthrough electronic brachytherapy technology to provide expanded treatment options for a range of cancers. With the Axxent controller, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
The source is placed inside the applicator and energized to deliver a precise, prescribed dose of radiation. With the Xoft System, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
The versatile Xoft Axxent Electronic Brachytherapy (eBx) System utilizes state-of-the-art 50kV x-ray technology to provide expanded treatment options for a range of cancers. The Xoft System provides isotope-free HDR therapeutic radiation of the disease target while sparing surrounding healthy ...
by:Kephera Diagnostics, LLC based inFramingham, MASSACHUSETTS (USA)
At Kephera, we are developing rapid tests for infectious diseases using novel immunochemistry in point-of-care format. Our proprietary assay technology is based on principles of particle interaction combined with a simple device, which together enable rapid detection of specific antibodies or antigens associated with the target pathogen. The broadly enabling ...
Manufactured by:Roche Diagnostics International AG based inRotkreuz, SWITZERLAND
The XT-8 system is the pioneer of true multiplex molecular testing, offering post-PCR detection for infectious disease, genetics, and pharmacogenetics ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
MolEQ designs novel compounds by optimizing multiple properties such as efficacy and toxicity of a lead ...
Manufactured by:Symberix, Inc. based inDurham, NORTH CAROLINA (USA)
Trillions of microorganisms colonize the human body and play a central role in health and disease. Symbiotic drugs target bacteria to improve human health while leaving good microbes ...
Manufactured by:CathWorks based inIrvine, CALIFORNIA (USA)
Wire-free and drug-free 3D FFR guidance, practical for every case. Interactive 3D reconstruction of coronary tree, color-coded by FFR value. Highly accurate FFR results for multiple vessels. Angiograms overlaid with QCA and FFR for anatomical context. Interactive vessel sizing tool and 3D QCA for procedural ...
Manufactured by:Novo Nordisk A/S based inBagsværd, DENMARK
Our proprietary GalXC technology leverages a naturally occurring biologic process, ribonucleic acid interference, RNAi, to create therapies that silence disease-causing genes. This platform enables Dicerna to create molecules that can effectively interfere with the RNAi processes that lead to defective or misregulated proteins that cause disease. ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
GenePro LAMP SARS-CoV-2 Test kit is a real-time reverse transcription loop mediated isothermal amplification (real-time RT-LAMP) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens including oropharyngeal and nasopharyngeal swab, from individuals suspected of COVID-19 by their healthcare provider. It allows qualitative detection of RdRp gene ...
Manufactured by:Suono Bio based inFoxborough, MASSACHUSETTS (USA)
This enables us to “push” virtually any therapeutic class, including temperamental molecules, like nucleic acids, directly into cells with astounding efficacy and accuracy, affecting historically "undruggable" targets. We harness the power of ultrasound-induced cavitation to achieve this delivery and are applying it to creating new treatments for a variety of ...
by:Dyno Therapeutics based inWatertown, MASSACHUSETTS (USA)
Our CapsidMap™ platform uses AI to systematically and rapidly optimize AAV capsids, overcoming the limitations of naturally occurring virus capsids by improving targeting ability, payload size, immune evasion and manufacturability. By building a massive and detailed map of synthetic AAV capsid sequence space, we can quickly navigate the landscape to find enhanced gene therapy vectors with ...